Search research articles
Contact Us
Filters
Showing results (1111-1120 of 1,298) with videos related to
Page
of 130
Sort By:
Science Translational Medicine
|
June 2, 2017
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in <i>RAS</i> mutant cancers
Chaoyang Sun, Yong Fang, Jun Yin, et al.
Nature Biotechnology
|
May 13, 2020
Multiplex digital spatial profiling of proteins and RNA in fixed tissue
Christopher R Merritt, Giang T Ong, Sarah E Church, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2015
Personalized Preclinical Trials in BRAF Inhibitor-Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies
Clemens Krepler, Min Xiao, Katrin Sproesser, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 19, 2010
PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer
Sherene Loi, Benjamin Haibe-Kains, Samira Majjaj, et al.
Cancer Research
|
October 10, 2014
Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanoma
Y N Vashisht Gopal, Helen Rizos, Guo Chen, et al.
Cell Reports
|
November 1, 2018
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Yumeng Wang, Xiaoyan Xu, Dejan Maglic, et al.
Journal of the National Cancer Institute
|
April 12, 2015
A decision support framework for genomically informed investigational cancer therapy
Funda Meric-Bernstam, Amber Johnson, Vijaykumar Holla, et al.
JCI Insight
|
September 21, 2021
Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer
Mehdi Bouhaddou, Rex H Lee, Hua Li, et al.
Cell Reports. Medicine
|
December 21, 2022
Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis
Bin Yang, Xiong Li, Wei Zhang, et al.
Nature Communications
|
April 1, 2021
Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response
Dimitra Georgopoulou, Maurizio Callari, Oscar M Rueda, et al.
Page
of 130
Search research articles
Search
Showing results (1111-1120 of 1,298) with videos related to
Sort By:
Page
of 130
Science Translational Medicine
|
June 2, 2017
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in <i>RAS</i> mutant cancers
Chaoyang Sun, Yong Fang, Jun Yin, et al.
Nature Biotechnology
|
May 13, 2020
Multiplex digital spatial profiling of proteins and RNA in fixed tissue
Christopher R Merritt, Giang T Ong, Sarah E Church, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2015
Personalized Preclinical Trials in BRAF Inhibitor-Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies
Clemens Krepler, Min Xiao, Katrin Sproesser, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 19, 2010
PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer
Sherene Loi, Benjamin Haibe-Kains, Samira Majjaj, et al.
Cancer Research
|
October 10, 2014
Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanoma
Y N Vashisht Gopal, Helen Rizos, Guo Chen, et al.
Cell Reports
|
November 1, 2018
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Yumeng Wang, Xiaoyan Xu, Dejan Maglic, et al.
Journal of the National Cancer Institute
|
April 12, 2015
A decision support framework for genomically informed investigational cancer therapy
Funda Meric-Bernstam, Amber Johnson, Vijaykumar Holla, et al.
JCI Insight
|
September 21, 2021
Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer
Mehdi Bouhaddou, Rex H Lee, Hua Li, et al.
Cell Reports. Medicine
|
December 21, 2022
Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis
Bin Yang, Xiong Li, Wei Zhang, et al.
Nature Communications
|
April 1, 2021
Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response
Dimitra Georgopoulou, Maurizio Callari, Oscar M Rueda, et al.
Page
of 130